-
Forbion Capital Partner Invests EUR 2.4 Million in 2nd Closing of Series A Financing Round for Rigontec GmbH
March 24, 2015For immediate release 24 March 2015  Forbion Capital Partners Invests EUR 2.4 Million in 2nd Closing of Series...
0 -
Forbion Announces Sale of Portfolio Company PneumRx
December 5, 2014Forbion Announces Sale of Portfolio Company PneumRx to BTG for up to USD 475M (EUR 385M) Naarden, The Netherlands, December...
-
Forbion Capital Partners Announces First Close of FCF III
October 3, 2014For immediate release 3 October 2014 Forbion Capital Partners Announces First Close of FCF III Naarden, The...
-
Forbion Portfolio Company News: Dezima
September 12, 2014Dezima Reports Positive Results in its Phase 2b TULIP Trial with CETP Inhibitor TA-8995 in Dyslipidemia Combines outstanding efficacy...
-
Venture Capital in the Life Sciences Space the Time is NOW
September 12, 2014This 18 min video that was made of Sander van Deventer presenting at a Moscow Life Sciences Investment Day...
-
Forbion announces Sale of Portfolio Company, Santaris Pharma, to Roche for up to $450m
August 18, 2014For immediate release 5 August 2014 Forbion Announces Sale of Portfolio Company, Santaris Pharma, to Roche for up to...
-
Gene therapy: A major therapeutic breakthrough uniQure – DIST 2013 – VIDEO
June 17, 2014Sander van Deventer is partner at Forbion and on the board of uniQure. He was the second speaker a DIST 2013....
-
Forbion in zee met rijke families om nieuwe medicijnen te ontwikkelen
June 3, 2014Article in the “Financieel Dagblad” Friday 23 May 2014. Click here to read.
-
Forbion Portfolio Company News
April 4, 2014Forbion’s portfolio company Hookipa Biotech is winner of the Best Financing Deal Award in the Vaccine Industry Excellence (ViE)...
-
For Biotech and Beyond
April 3, 2014True innovation is driven by a small minority who are able to create precedent rather than follow it.